Showing 21 - 40 results of 227,760 for search '(( 10 ((((we decrease) OR (nn decrease))) OR (a decrease)) ) OR ( 16 we decrease ))', query time: 1.63s Refine Results
  1. 21
  2. 22
  3. 23
  4. 24
  5. 25
  6. 26
  7. 27
  8. 28
  9. 29
  10. 30
  11. 31

    Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia by Yiting Zhang (391974)

    Published 2016
    “…Total Cbl was significantly lower in older control subjects (> 60 yrs of age), primarily reflecting a >10-fold age-dependent decline in the level of MeCbl. …”
  12. 32
  13. 33
  14. 34

    tuning. Percentage of clusters enriched for spatial annotations in networks predicted by GINI as a function of tuning parameter for data from development stage 9–10 and 13–16.... by Kriti Puniyani (469389)

    Published 2013
    “…Percentage of clusters enriched for spatial annotations in networks predicted by GINI as a function of tuning parameter for data from development stage 9–10 and 13–16. …”
  15. 35
  16. 36
  17. 37
  18. 38

    Table_1_Decreased synaptic vesicle glycoprotein 2A binding in a rodent model of familial Alzheimer's disease detected by [18F]SDM-16.DOCX by Chao Zheng (728465)

    Published 2023
    “…Introduction<p>Synapse loss is one of the hallmarks of Alzheimer's disease (AD) and is associated with cognitive decline. In this study, we tested [<sup>18</sup>F]SDM-16, a novel metabolically stable SV2A PET imaging probe, in the transgenic APPswe/PS1dE9 (APP/PS1) mouse model of AD and age-matched wild-type (WT) mice at 12 months of age.…”
  19. 39

    Supplementary Material for: Decreased Systemic Levels of Endocan-1 and CXCL16 in Psoriasis Are Restored following Narrowband UVB Treatment by Sigurdardottir G. (5710955)

    Published 2018
    “…<b><i>Methods:</i></b> The levels of 17 potential biomarkers with an association with cardiovascular risk were quantitated in plasma from 37 age- and gender-matched psoriasis patients and controls at baseline and in 21 psoriasis patients after 12 weeks of NB-UVB treatment to identify a systemic treatment response. <b><i>Results:</i></b> We identified the mediators endocan-1, CXCL16, and sVEGFR1, which were systemically decreased in psoriasis at baseline, as well as FABP3, FABP4, and sIL-1R1, which showed normal baseline levels. …”
  20. 40